2018: A Record-Breaking Year for Hematologic Drug Approvals
Your source for worldwide news and
perspectives on hematology/oncology
volume 05 | number 02
january 2019 annual meeting edition
CONTENTS
Written in Blood
Ravulizumab: A
New Option for
Paroxysmal Nocturnal
Hemoglobinuria
Literature Scan
Shortening Decitabine
Treatment in Older
Patients With AML
On Location
Ibrutinib Beats
Standard Therapy
in CLL
On Location
Luspatercept
Promising in Beta
Thalassemia and MDS
Highlights from the 2018
ASH ANNUAL MEETING
IMPROVING PROGNOSIS, TREATMENT, AND OUTCOMES FOR PATIENTS
WITH BLOOD DISORDERS WORLDWIDE
DEPARTMENTS
6 UP FRONT
7 CLINICAL NEWS
39 BACK OF THE BOOK
www.ASHClinicalNews.org
The Society Pages:
Recent Promotions
and Transitions
Latest & Greatest:
New and Noteworthy
Research
Data Stream:
Health-Care Facts
& Figures